Learning Objectives:
- Identify what biomarkers should be utilized to detect the most at-risk population, to detect the disease while measurable and yet not clinically apparent?
- identify the most relevant candidate biomarkers of early detection in Thoracic Cancers
- Describe critical aspects of study design in molecular biomarkers for early detection of lung cancer
Session date:
02/21/2017 - 6:45am to 7:45am CST
Location:
UCMC
E-500
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Jussuf Kaifi, MD, PhD